Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
- PMID: 1655948
- PMCID: PMC2118975
- DOI: 10.1084/jem.174.4.915
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
Abstract
Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4+ T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon gamma- or IL-4-induced, class II MHC expression on monocytes by IL-10 and v-IL-10, resulting in the reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen-presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed IL-1 alpha, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen-specific responses were observed in the presence of neutralizing anti-IL-1, -IL-6, and -TNF-alpha mAbs. Furthermore, addition of saturating concentrations of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha to the cultures had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.
Similar articles
-
Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.J Exp Med. 1995 Apr 1;181(4):1411-23. doi: 10.1084/jem.181.4.1411. J Exp Med. 1995. PMID: 7699327 Free PMC article.
-
Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.J Immunol. 1986 Jul 15;137(2):400-7. J Immunol. 1986. PMID: 2941479
-
Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.Eur J Immunol. 1986 Apr;16(4):370-5. doi: 10.1002/eji.1830160410. Eur J Immunol. 1986. PMID: 2422040
-
The mosaic of immunosuppressive drugs.Mol Immunol. 2003 Jul;39(17-18):1073-7. doi: 10.1016/s0161-5890(03)00075-0. Mol Immunol. 2003. PMID: 12835079 Review.
-
Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.Hum Immunol. 1984 Oct;11(2):77-97. doi: 10.1016/0198-8859(84)90047-8. Hum Immunol. 1984. PMID: 6092300 Review.
Cited by
-
IL22/IL-22R pathway induces cell survival in human glioblastoma cells.PLoS One. 2015 Mar 20;10(3):e0119872. doi: 10.1371/journal.pone.0119872. eCollection 2015. PLoS One. 2015. PMID: 25793261 Free PMC article.
-
A filarial parasite-encoded human IL-10 receptor antagonist reveals a novel strategy to modulate host responses.PNAS Nexus. 2022 Sep 7;1(4):pgac184. doi: 10.1093/pnasnexus/pgac184. eCollection 2022 Sep. PNAS Nexus. 2022. PMID: 36246151 Free PMC article.
-
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.Infect Immun. 1992 Jul;60(7):2880-6. doi: 10.1128/iai.60.7.2880-2886.1992. Infect Immun. 1992. PMID: 1612754 Free PMC article.
-
The molecular profile of microglia under the influence of glioma.Neuro Oncol. 2012 Aug;14(8):958-78. doi: 10.1093/neuonc/nos116. Epub 2012 May 9. Neuro Oncol. 2012. PMID: 22573310 Free PMC article. Review.
-
The cancer stem cell: evidence for its origin as an injured autoreactive T cell.Mol Cancer. 2006 Feb 14;5:6. doi: 10.1186/1476-4598-5-6. Mol Cancer. 2006. PMID: 16478542 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous